不要用理所当然来指导临床治疗思路 对于有病理MVI的患者或者病毒性肝炎的患者来说预防性的介入治疗是对于OS有意义 但是是否需要还是要根据的病史病理可以参考以下两篇近两年文献1、FEATURED
Published in Oncology
Journal Scan / Research · May 10, 2018
Adjuvant Transarterial Chemoembolization for HBV-Related HCC After Resection
Clinical Cancer Research 2、Postoperative adjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of hepatocellular carcinoma patients with microvascular invasion: A preliminary report of a phase III, randomized, controlled clinical trial.